Gts Securities LLC Bluebird Bio, Inc. Call Options Transaction History

Gts Securities LLC

  • $46.5 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$0.85 - $1.26 $14,025 - $20,790
-16,500 Reduced 26.32%
46,200 $45,000
Q1 2024

May 15, 2024
SELL
$0.91 - $1.75 $160,160 - $308,000
-176,000 Reduced 73.73%
62,700 $80,000
Q4 2023

Feb 14, 2024
BUY
$1.32 - $4.83 $167,244 - $611,961
126,700 Added 113.13%
238,700 $329,000
Q3 2023

Nov 15, 2023
BUY
$3.02 - $4.05 $338,240 - $453,600
112,000 New
112,000 $340,000

Others Institutions Holding BLUE

# of Institutions
162
Shares Held
79.9M
Call Options Held
525K
Put Options Held
634K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $38.6M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email